Alan Kohler and David Langsam do your research

…. he doesn’t speak highly of the DEP technology either - “results patchy at best” ?

Not sure how he would know this given what has been made public thus far seems very positive …. well that is of course what JF & Co. have told us with the case studies in the shareholder updates and the comments made by both the CEO and Chairman at AGM’s etc ?

Like others have said, AK didn’t appear impressed with JF and it was one of the worst she has done IMO

maybe he was also meaning patchy for the ability to license the DEP technology to partners other than AZ. “ undisclosed ” reserch partners and others over many years but only real deal is AZ deal in 2015 now into clinic phase 1. second AZ deal in 2016 is taking long time to move to clinic or announce anything about it.